144 related articles for article (PubMed ID: 2445907)
21. The 2-5A system in control and interferon-treated K/BALB cells infected with encephalomyocarditis virus.
Meurs E; Krause D; Robert N; Silverman RH; Hovanessian AG
Prog Clin Biol Res; 1985; 202():307-15. PubMed ID: 2421309
[No Abstract] [Full Text] [Related]
22. Interferon-mediated antiviral state in human MRC5 cells in the absence of detectable levels of 2-5A synthetase and protein kinase.
Meurs E; Hovanessian AG; Montagnier L
J Interferon Res; 1981 Feb; 1(2):219-32. PubMed ID: 6180053
[TBL] [Abstract][Full Text] [Related]
23. Effects of interferon on sensitive and resistant L1210 cell lines.
Marti J; Vandenbussche P; Silhol M; Milhaud P; Verhaegen M; Content J; Lebleu B
J Interferon Res; 1981 Feb; 1(2):287-95. PubMed ID: 6180059
[TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of interferon-resistant variants from S49 mouse lymphoma.
Hochman J; Mador N; Gloger I; Falk H; Panet A
Exp Cell Res; 1988 Jul; 177(1):37-46. PubMed ID: 2455652
[TBL] [Abstract][Full Text] [Related]
25. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes.
Khabar KS; Dhalla M; Siddiqui Y; Zhou A; Al-Ahdal MN; Der SD; Silverman RH; Williams BR
J Interferon Cytokine Res; 2000 Jul; 20(7):653-9. PubMed ID: 10926208
[TBL] [Abstract][Full Text] [Related]
26. Interferon action in human fibroblasts: induction of 2', 5'-oligoadenylate synthetase in the absence of detectable protein kinase activity.
Holmes SL; Gupta SL
Arch Virol; 1982; 72(1-2):137-42. PubMed ID: 6179503
[TBL] [Abstract][Full Text] [Related]
27. Human interferon suppression of retrovirus production and cell fusion, and failure to inhibit replication of encephalomyocarditis virus in rhabdomyosarcoma (RD114) cells.
Tomita Y; Nishimaki J; Takahashi F; Kuwata T
Virology; 1982 Jul; 120(1):258-63. PubMed ID: 6179291
[No Abstract] [Full Text] [Related]
28. Brefeldin A inhibits the antiviral action of interferon against encephalomyocarditis virus.
Sidhu GS; Singh AK; Raghunath PN; Sivaram S; Maheshwari RK
Virus Res; 1996 Feb; 40(2):123-33. PubMed ID: 8725108
[TBL] [Abstract][Full Text] [Related]
29. Constitutive expression of a 2',5'-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression.
Rysiecki G; Gewert DR; Williams BR
J Interferon Res; 1989 Dec; 9(6):649-57. PubMed ID: 2481699
[TBL] [Abstract][Full Text] [Related]
30. Effects of human gamma interferon on cell growth, replication of virus and induction of 2'-5'oligoadenylate synthetase in three human lymphoblastoid cell lines and K562 cells.
Tomita Y; Cantell K; Kuwata T
Int J Cancer; 1982 Aug; 30(2):161-5. PubMed ID: 6182110
[TBL] [Abstract][Full Text] [Related]
31. Induction of anti-viral activity and specific enzymes in cell-lines derived from interferon-resistant, thymidine kinase deficient mouse L-929 cells.
Lewis JA
Prog Clin Biol Res; 1985; 202():325-32. PubMed ID: 2421311
[No Abstract] [Full Text] [Related]
32. Lack of systematic correlation between the interferon mediated antiviral state and the levels of 2-5A synthetase and protein kinase in three different types of murine cells.
Hovanessian AG; Meurs E; Montagnier L
J Interferon Res; 1981 Feb; 1(2):179-90. PubMed ID: 6286803
[TBL] [Abstract][Full Text] [Related]
33. 2'-5'-oligoadenylate synthetase gene expression in normal and murine sarcoma virus-transformed NIH 3T3 cells.
David S; Nissim A; Chebath J; Salzberg S
J Virol; 1989 Mar; 63(3):1116-22. PubMed ID: 2536824
[TBL] [Abstract][Full Text] [Related]
34. Involvement of interferon-system in the regulation of cell growth and differentiation.
Salzberg S; Hacohen D; David S; Dovrat S; Ahwan S; Gamliel H; Birnbaum M
Scanning Microsc; 1990 Jun; 4(2):479-89. PubMed ID: 1698310
[TBL] [Abstract][Full Text] [Related]
35. Role of interferon and 2',5'-oligoadenylate synthetase in erythroid differentiation of Friend leukemia cells. Studies with interferon-sensitive and -resistant variants.
Mechti N; Affabris E; Romeo G; Lebleu B; Rossi GB
J Biol Chem; 1984 Mar; 259(5):3261-5. PubMed ID: 6321503
[TBL] [Abstract][Full Text] [Related]
36. Dissociable antiviral activities directed against cardioviruses are expressed in L cells treated with interferon.
Monahan SJ; Simon E
J Gen Virol; 1992 Sep; 73 ( Pt 9)():2299-303. PubMed ID: 1383407
[TBL] [Abstract][Full Text] [Related]
37. Induction of an antiviral state by interferon in the absence of elevated levels of 2,5-oligo(A) synthetase and eIF-2 kinase.
Lewis JA
Virology; 1988 Jan; 162(1):118-27. PubMed ID: 2447700
[TBL] [Abstract][Full Text] [Related]
38. Levels of 2',5'-oligoadenylates in the tissues of pathogen-free mice.
Hearl WG; Johnston MI
Prog Clin Biol Res; 1985; 202():19-24. PubMed ID: 2421302
[TBL] [Abstract][Full Text] [Related]
39. Analysis of interferon actions using partially resistant cell variants.
Sen G; Belkowski L; Kusari J
Prog Clin Biol Res; 1985; 202():175-82. PubMed ID: 2421300
[No Abstract] [Full Text] [Related]
40. Heterogeneous nuclear RNA from hairy cell leukemia patients activates 2',5'-oligoadenylate synthetase.
Hubbell HR; Sheetz PC; Iogal SS; Brodsky I; Kariko K; Li SW; Suhadolnik RJ; Sobol RW
Anticancer Res; 1991; 11(5):1927-32. PubMed ID: 1768064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
